Genetic Variants of DNA Repair Genes Predict the Survival of Patients with Esophageal Squamous Cell Cancer Receiving Platinum-Based Adjuvant Chemotherapy.

Fei Zhou,Meiling Zhu,Mengyun Wang,Lixin Qiu,Lei Cheng,Ming Jia,Jiaqing Xiang,Qingyi Wei
DOI: https://doi.org/10.1186/s12967-016-0903-z
IF: 8.44
2016-01-01
Journal of Translational Medicine
Abstract:Adjuvant chemotherapy in patients with resected esophageal squamous cell cancer (ESCC) remains controversial for its uncertain role in improving overall survival (OS). Nucleotide excision repair (NER) removes DNA-adducts in tumor cells induced by the platinum-based chemotherapy and thus may modulate efficacy of the treatment. The present study evaluated if single nucleotide polymorphisms (SNPs) of NER genes were prognostic biomarkers in ESCC patients treated with platinum-based adjuvant chemotherapy (PAC).
What problem does this paper attempt to address?